Colestilan (BindRen®) approved in the EU for treatment of hyperphosphataemia in adults with CKD

Source: European Medicines Agency Area: News Colestilan (BindRen®) has been approved in the EU for the treatment of hyperphosphataemia in adult patients with Chronic Kidney Disease (CKD) Stage 5 receiving haemodialysis or peritoneal dialysis. Further details of this product, including the European Public Assessment Report, are available via link below.  
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news